User profiles for Srikanth P Tripathy
 | Srikanth TripathyDr DY Patil Medical College, Hospital and Research Centre, Pune Verified email at dpu.edu.in Cited by 11293 |
[HTML][HTML] Systemic inflammation and the increased risk of inflamm-aging and age-associated diseases in people living with HIV on long term suppressive antiretroviral …
…, R Sridhar, SP Tripathy, P Nowak… - Frontiers in …, 2019 - frontiersin.org
The ART program in low- and middle-income countries (LMIC) like India, follows a public
health approach with a standardized regimen for all people living with HIV (PLHIV). Based on …
health approach with a standardized regimen for all people living with HIV (PLHIV). Based on …
Role of neutrophils in tuberculosis: a bird's eye view
Neutrophils are innate immune cells implicated in the process of killing Mycobacterium
tuberculosis early during infection. Once the mycobacteria enter the human system, neutrophils …
tuberculosis early during infection. Once the mycobacteria enter the human system, neutrophils …
[HTML][HTML] Plasma metabolic signature and abnormalities in HIV-infected individuals on long-term successful antiretroviral therapy
…, G Rachel, VK Viswanathan, SP Tripathy, P Nowak… - Metabolites, 2019 - mdpi.com
Targeted metabolomics studies reported metabolic abnormalities in both treated and
untreated people living with human immunodeficiency virus (HIV) (PLHIV). The present study …
untreated people living with human immunodeficiency virus (HIV) (PLHIV). The present study …
[HTML][HTML] Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study
Background NVX-CoV2373, a Covid-19 vaccine was developed in the USA with ∼90%
efficacy. The same vaccine is manufactured in India after technology transfer (called as SII-NVX-…
efficacy. The same vaccine is manufactured in India after technology transfer (called as SII-NVX-…
Mycobacterium tuberculosis lineages associated with mutations and drug resistance in isolates from India
…, SP Tripathy, M Natrajan, P Chandrasekaran… - Microbiology …, 2022 - Am Soc Microbiol
Current knowledge on resistance-conferring determinants in Mycobacterium tuberculosis is
biased toward globally dominant lineages 2 and 4. In contrast, lineages 1 and 3 are …
biased toward globally dominant lineages 2 and 4. In contrast, lineages 1 and 3 are …
[HTML][HTML] Outcome of patients on second line antiretroviral therapy under programmatic condition in India
…, A Chourasia, PN Singh, S Kurle, SP Tripathy… - BMC infectious …, 2015 - Springer
Background The National AIDS Control Organization of India has been providing free second
line antiretroviral therapy (ART) since 2008. This observational study reports the survival …
line antiretroviral therapy (ART) since 2008. This observational study reports the survival …
[HTML][HTML] An influence of dew point temperature on the occurrence of Mycobacterium tuberculosis disease in Chennai, India
…, SP Tripathy, P Chinnaiyan, P Chandrasekaran - Scientific reports, 2022 - nature.com
Climate factors such as dew point temperature, relative humidity and atmospheric temperature
may be crucial for the spread of tuberculosis. This study was conducted for the first time to …
may be crucial for the spread of tuberculosis. This study was conducted for the first time to …
Current trends in tuberculosis vaccine
…, UD Ranganathan, SP Tripathy - medical journal armed …, 2019 - Elsevier
Despite the global efforts made to control tuberculosis (TB) and the large number of available
new anti-TB drugs, TB still affects one-third of the world population. The conventional …
new anti-TB drugs, TB still affects one-third of the world population. The conventional …
Unique phenotypic characteristics of recently transmitted HIV-1 subtype C envelope glycoprotein gp120: use of CXCR6 coreceptor by transmitted founder viruses
M Ashokkumar, SG Aralaguppe, SP Tripathy… - Journal of …, 2018 - Am Soc Microbiol
Adequate information on the precise molecular and biological composition of the viral strains
that establish HIV infection in the human host will provide effective means of immunization …
that establish HIV infection in the human host will provide effective means of immunization …
Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India
…, R Singla, D Surie, J Tonsing, SP Tripathy… - BMJ global …, 2018 - gh.bmj.com
The End TB Strategy envisions a world free of tuberculosis—zero deaths, disease and
suffering due to tuberculosis by 2035. This requires reducing the global tuberculosis incidence …
suffering due to tuberculosis by 2035. This requires reducing the global tuberculosis incidence …